CVE-2025-23039 - "Caido Cross-Site Scripting Vulnerability"
CVE ID : CVE-2025-23039 Published : Jan. 17, 2025, 9:15 p.m. | 2 hours, 29 minutes ago Description : Caido is a web security auditing toolkit. A Cross-Site Scripting (XSS) vulnerability was identified in Caido v0.45.0 due to improper sanitization in the URL decoding tooltip of HTTP request and response editors. This issue could allow an attacker to execute arbitrary scripts, potentially leading to the theft of sensitive information. This issue has been addressed in version 0.45.1 and all users are advised to upgrade. There are no known workarounds for this vulnerability. Severity: 5.2 | MEDIUM Visit the link for more details, such as CVSS details, affected products, timeline, and more...
CVE ID : CVE-2025-23039
Published : Jan. 17, 2025, 9:15 p.m. | 2 hours, 29 minutes ago
Description : Caido is a web security auditing toolkit. A Cross-Site Scripting (XSS) vulnerability was identified in Caido v0.45.0 due to improper sanitization in the URL decoding tooltip of HTTP request and response editors. This issue could allow an attacker to execute arbitrary scripts, potentially leading to the theft of sensitive information. This issue has been addressed in version 0.45.1 and all users are advised to upgrade. There are no known workarounds for this vulnerability.
Severity: 5.2 | MEDIUM
Visit the link for more details, such as CVSS details, affected products, timeline, and more...
Published : Jan. 17, 2025, 9:15 p.m. | 2 hours, 29 minutes ago
Description : Caido is a web security auditing toolkit. A Cross-Site Scripting (XSS) vulnerability was identified in Caido v0.45.0 due to improper sanitization in the URL decoding tooltip of HTTP request and response editors. This issue could allow an attacker to execute arbitrary scripts, potentially leading to the theft of sensitive information. This issue has been addressed in version 0.45.1 and all users are advised to upgrade. There are no known workarounds for this vulnerability.
Severity: 5.2 | MEDIUM
Visit the link for more details, such as CVSS details, affected products, timeline, and more...
